Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis

BACKGROUND: Vonoprazan, a novel acid-suppressive drug, is non-inferior to proton pump inhibitors (PPIs) for the management of gastric acid-related diseases. However, the safety of vonoprazan has not been systematically evaluated yet. OBJECTIVES: To elucidate the incidence and type of adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wentao, Bai, Zhaohui, Shang, Yiyang, Wang, Jing, Wong, Yujun, Qi, Xingshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126681/
https://www.ncbi.nlm.nih.gov/pubmed/37113190
http://dx.doi.org/10.1177/17562848231167858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126681/
https://www.ncbi.nlm.nih.gov/pubmed/37113190
http://dx.doi.org/10.1177/17562848231167858

Ejemplares similares